Anthera Refinances Existing Debt with New $20 Million Credit Facility and Secures $18.5 Million Committed Equity Financing Facility
Yahoo/PR Newswire
Anthera Pharmaceuticals Trading Higher On Additional Data; Need For Capital Could Cap Upside
Seeking Alpha
Anthera announces advancement of blisibimod in Phase 3 development
The Fly on the Wall
4 Reasons To Buy Anthera Pharmaceuticals
Seeking Alpha
A Long Shot In The Lupus Market Gains Attention
Seeking Alpha
22 Biopharma Stocks With Breakout Potential in 2012
Seeking Alpha

